Marlene and Stewart Greenebaum Cancer Center — Baltimore, Maryland

Marlene and Stewart Greenebaum Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Marlene and Stewart Greenebaum Cancer Center has participated in 3 clinical trials.

Therapeutic areas: Advanced Solid Tumors, Hematopoietic Stem Cells, HRAS Gene Mutation.

Sponsors: Array Biopharma, now a wholly owned subsidiary of Pfizer, Millennium Pharmaceuticals, Inc., Kura Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Marlene and Stewart Greenebaum Cancer Center?

Marlene and Stewart Greenebaum Cancer Center has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Marlene and Stewart Greenebaum Cancer Center conducted?

Marlene and Stewart Greenebaum Cancer Center has 3 clinical trials on record. Their work covers Advanced Solid Tumors, Hematopoietic Stem Cells, HRAS Gene Mutation.

Is Marlene and Stewart Greenebaum Cancer Center accredited by Crixeo Health?

Marlene and Stewart Greenebaum Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Marlene and Stewart Greenebaum Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.